TY  - GEN
AU  - Lin,T
AU  - Wang,C
AU  - Cai,X-Z
AU  - Zhao,X
AU  - Shi,M-M
AU  - Ying,Z-M
AU  - Yuan,F-Z
AU  - Guo,C
AU  - Yan,S-G
TI  - Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis
SN  - 1742-1241
PY  - 2012///0523
KW  - Aged
KW  - Aged, 80 and over
KW  - Alendronate
KW  - therapeutic use
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - Denosumab
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Female
KW  - Humans
KW  - Multicenter Studies as Topic
KW  - Osteoporosis, Postmenopausal
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1111/j.1742-1241.2011.02806.x
ER  -